中文
Value GiantsValue investors’ 13F holdings, as a whole
Q2 2026 13FData as of Aug 18, 2026
Sector

Health Care

Q2 2026: 6.8% of the giants’ composite, 91 companies held; estimated net selling of $356.5M this quarter.

I

The 20 Most Heavily Held Companies in This Sector

Ranked by composite weight.

RankCompanyGiants holdingComposite weightThis quarterNet (est.)Pricevs cost
1ICLRIcon PLC50.49%bought 3 sold 1+$182.6M$173.71+3%
2ELVElevance Health, Inc60.46%bought 2 sold 4−$311.0M$386.73+13%
3AZNAstraZeneca PLC10.33%bought 1 sold 0+$374.4M$189.62−3%
4UNHUnitedHealth Group Inc110.33%bought 5 sold 6−$364.1M$415.63+21%
5SOLVSolventum Corp20.29%bought 0 sold 0$0$77.15+23%
6RPRXRoyalty Pharma plc20.27%bought 1 sold 1+$7.0M$56.07+68%
7ALCAlcon Inc10.26%bought 1 sold 1−$153.2M$67.21−6%
8BDXBecton Dickinson and Co30.24%bought 2 sold 1+$896.7M$151.33−6%
9IONSIonis Pharmaceuticals Inc10.24%bought 0 sold 0$0$79.29+124%
10MRKMerck & Co., Inc60.24%bought 1 sold 3−$5.7M$128.50+56%
11XRAYDentsply Sirona Inc10.21%bought 1 sold 0+$17.7M$10.61−5%
12SYKStryker Corp30.20%bought 0 sold 3−$199.1M$314.84+50%
13JNJJohnson & Johnson70.17%bought 1 sold 3−$1.9M$253.97+107%
14VTRSViatris Inc30.16%bought 1 sold 1−$29.7M$15.88+13%
15GEHCGE HealthCare Technologies Inc40.13%bought 3 sold 0+$307.4M$64.01−12%
16ZTSZoetis Inc40.13%bought 3 sold 3−$316.2M$71.86−29%
17MEDPMedpace Holdings, Inc30.12%bought 0 sold 2−$37.2M$529.59+43%
18INDVIndivior Pharmaceuticals, Inc10.11%bought 0 sold 1−$30.6M$41.03+35%
19IDXXIdexx Laboratories Inc30.11%bought 1 sold 1−$271.2M$526.44+38%
20TECHBio-Techne Corp20.11%bought 0 sold 2−$9.4M$70.65+13%
II

Money Flows

Estimated Net Buying (Last 20 Quarters)

Health Care: Estimated Net Buying Each Quarter−$4.0B−$2.0B$0$2.0BQ3 2021Q1 2022Q3 2022Q1 2023Q3 2023Q1 2024Q3 2024Q1 2025Q3 2025Q2 2026

Share of the Composite (from 2013)

Health Care Share of the Composite0%2%5%8%Q2 2013Q4 2014Q2 2016Q4 2017Q2 2019Q4 2020Q2 2022Q4 2023Q2 2026
III

Giants Most Invested in This Sector